Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors

Abstract Dickkopf-1 (DKK1) is a secreted modulator of Wnt signaling that is frequently overexpressed in tumors and associated with poor clinical outcomes. DKN-01 is a humanized monoclonal therapeutic antibody that binds DKK1 with high affinity and has demonstrated clinical activity in gastric/gastro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Charles Caldwell, James B. Rottman, Will Paces, Elizabeth Bueche, Sofia Reitsma, Joseph Gibb, Vitria Adisetiyo, Michael S. Haas, Heidi Heath, Walter Newman, Jason Baum, Roberto Gianani, Michael H. Kagey
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/386bfb9934384f32ac9a8bd2228acb37
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:386bfb9934384f32ac9a8bd2228acb37
record_format dspace
spelling oai:doaj.org-article:386bfb9934384f32ac9a8bd2228acb372021-12-02T17:01:43ZValidation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors10.1038/s41598-021-89060-32045-2322https://doaj.org/article/386bfb9934384f32ac9a8bd2228acb372021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-89060-3https://doaj.org/toc/2045-2322Abstract Dickkopf-1 (DKK1) is a secreted modulator of Wnt signaling that is frequently overexpressed in tumors and associated with poor clinical outcomes. DKN-01 is a humanized monoclonal therapeutic antibody that binds DKK1 with high affinity and has demonstrated clinical activity in gastric/gastroesophageal junction (G/GEJ) patients with elevated tumoral expression of DKK1. Here we report on the validation of a DKK1 RNAscope chromogenic in situ hybridization assay to assess DKK1 expression in G/GEJ tumor tissue. To reduce pathologist time, potential pathologist variability from manual scoring and support pathologist decision making, a digital image analysis algorithm that identifies tumor cells and quantifies the DKK1 signal was developed. Following CLIA guidelines the DKK1 RNAscope chromogenic in situ hybridization assay and digital image analysis algorithm were successfully validated for sensitivity, specificity, accuracy, and precision. The DKK1 RNAscope assay in conjunction with the digital image analysis solution is acceptable for prospective screening of G/GEJ adenocarcinoma patients. The work described here will further advance the companion diagnostic development of our DKK1 RNAscope assay and could generally be used as a guide for the validation of RNAscope assays with digital image quantification.Charles CaldwellJames B. RottmanWill PacesElizabeth BuecheSofia ReitsmaJoseph GibbVitria AdisetiyoMichael S. HaasHeidi HeathWalter NewmanJason BaumRoberto GiananiMichael H. KageyNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Charles Caldwell
James B. Rottman
Will Paces
Elizabeth Bueche
Sofia Reitsma
Joseph Gibb
Vitria Adisetiyo
Michael S. Haas
Heidi Heath
Walter Newman
Jason Baum
Roberto Gianani
Michael H. Kagey
Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors
description Abstract Dickkopf-1 (DKK1) is a secreted modulator of Wnt signaling that is frequently overexpressed in tumors and associated with poor clinical outcomes. DKN-01 is a humanized monoclonal therapeutic antibody that binds DKK1 with high affinity and has demonstrated clinical activity in gastric/gastroesophageal junction (G/GEJ) patients with elevated tumoral expression of DKK1. Here we report on the validation of a DKK1 RNAscope chromogenic in situ hybridization assay to assess DKK1 expression in G/GEJ tumor tissue. To reduce pathologist time, potential pathologist variability from manual scoring and support pathologist decision making, a digital image analysis algorithm that identifies tumor cells and quantifies the DKK1 signal was developed. Following CLIA guidelines the DKK1 RNAscope chromogenic in situ hybridization assay and digital image analysis algorithm were successfully validated for sensitivity, specificity, accuracy, and precision. The DKK1 RNAscope assay in conjunction with the digital image analysis solution is acceptable for prospective screening of G/GEJ adenocarcinoma patients. The work described here will further advance the companion diagnostic development of our DKK1 RNAscope assay and could generally be used as a guide for the validation of RNAscope assays with digital image quantification.
format article
author Charles Caldwell
James B. Rottman
Will Paces
Elizabeth Bueche
Sofia Reitsma
Joseph Gibb
Vitria Adisetiyo
Michael S. Haas
Heidi Heath
Walter Newman
Jason Baum
Roberto Gianani
Michael H. Kagey
author_facet Charles Caldwell
James B. Rottman
Will Paces
Elizabeth Bueche
Sofia Reitsma
Joseph Gibb
Vitria Adisetiyo
Michael S. Haas
Heidi Heath
Walter Newman
Jason Baum
Roberto Gianani
Michael H. Kagey
author_sort Charles Caldwell
title Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors
title_short Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors
title_full Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors
title_fullStr Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors
title_full_unstemmed Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors
title_sort validation of a dkk1 rnascope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/386bfb9934384f32ac9a8bd2228acb37
work_keys_str_mv AT charlescaldwell validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT jamesbrottman validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT willpaces validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT elizabethbueche validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT sofiareitsma validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT josephgibb validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT vitriaadisetiyo validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT michaelshaas validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT heidiheath validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT walternewman validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT jasonbaum validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT robertogianani validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT michaelhkagey validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
_version_ 1718382061980483584